Clinical outcomes of patients with mitral prosthetic valve obstructive thrombosis treated with streptokinase or tenecteplase

Agent of choice for thrombolytic therapy (TT) in prosthetic valve thrombosis (PVT) is unknown. 84 mitral obstructive-PVT episodes treated with TT (43: Tenecteplase; 41: Streptokinase) were included in this prospective study. The incidence of primary end-point (CCS: complete clinical success, defined...

Descripción completa

Detalles Bibliográficos
Autores principales: Kiran, G. Ravi, Chandrasekhar, P., Mohammad Ali, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research Brief
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8322749/
https://www.ncbi.nlm.nih.gov/pubmed/34154758
http://dx.doi.org/10.1016/j.ihj.2021.02.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8322749/
https://www.ncbi.nlm.nih.gov/pubmed/34154758
http://dx.doi.org/10.1016/j.ihj.2021.02.005

Ejemplares similares